Bacillus methanolicus MGA3
(NCBI:txid796606)
|
See:
MetaboLights Study
|
Bacillus methanolicus MGA3
(NCBI:txid796606)
|
See:
PubMed
|
antipsoriatic
A drug used to treat psoriasis.
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
|
|
2-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-1,2,4-triazine-3,5(2H,4H)-dione
|
2',3',5'-Tri-O-acetyl-6-azauridine
|
ChemIDplus
|
2',3',5'-Triacetyl-6-azauridine
|
ChemIDplus
|
2-(2',3',5'-Triacetyl-beta-D-ribofuranosyl)-as-triazine-3,5-(2H,4H)-dione
|
ChemIDplus
|
2-beta-D-Ribofuranosyl-as-triazine-3,5(2H,4H)-dione 2',3',5'-triacetate
|
ChemIDplus
|
6-Azauridine 2',3',5'-triacetate
|
ChemIDplus
|
Triacetyl-6-azauridine
|
ChemIDplus
|
2169-64-4
|
CAS Registry Number
|
ChemIDplus
|
631776
|
Beilstein Registry Number
|
ChemIDplus
|
631776
|
Reaxys Registry Number
|
Reaxys
|